172 related articles for article (PubMed ID: 20735381)
1. Detection of circulating tumour cells in peripheral blood of patients with advanced non-metastatic bladder cancer.
Rink M; Chun FK; Minner S; Friedrich M; Mauermann O; Heinzer H; Huland H; Fisch M; Pantel K; Riethdorf S
BJU Int; 2011 May; 107(10):1668-75. PubMed ID: 20735381
[TBL] [Abstract][Full Text] [Related]
2. Detection of circulating urothelial cancer cells in the blood using the CellSearch System.
Naoe M; Ogawa Y; Morita J; Omori K; Takeshita K; Shichijyo T; Okumura T; Igarashi A; Yanaihara A; Iwamoto S; Fukagai T; Miyazaki A; Yoshida H
Cancer; 2007 Apr; 109(7):1439-45. PubMed ID: 17326057
[TBL] [Abstract][Full Text] [Related]
3. [Mechanisms of tumour cell dissemination and methods for detection of circulating tumour cells in transitional cell carcinoma].
Schilling D; Todenhöfer T; Taran FA; Hartkopf A; Stenzl A; Fehm T
Aktuelle Urol; 2011 Mar; 42(2):122-7. PubMed ID: 21437836
[TBL] [Abstract][Full Text] [Related]
4. Detection of circulating tumor cells in bladder cancer patients.
Nezos A; Pissimisis N; Lembessis P; Sourla A; Dimopoulos P; Dimopoulos T; Tzelepis K; Koutsilieris M
Cancer Treat Rev; 2009 May; 35(3):272-9. PubMed ID: 19103472
[TBL] [Abstract][Full Text] [Related]
5. Isolation and enrichment of urologic tumor cells in blood samples by a semi-automated CD45 depletion autoMACS protocol.
Meye A; Bilkenroth U; Schmidt U; Füssel S; Robel K; Melchior AM; Blümke K; Pinkert D; Bartel F; Linne C; Taubert H; Wirth MP
Int J Oncol; 2002 Sep; 21(3):521-30. PubMed ID: 12168095
[TBL] [Abstract][Full Text] [Related]
6. The effects of transurethral resection and cystoprostatectomy on dissemination of epithelial cells in the circulation of patients with bladder cancer.
Desgrandchamps F; Teren M; Dal Cortivo L; Marolleau JP; Bertheau P; Villette JM; Cortesse A; Teillac P; Le Duc A; Hamdy FC
Br J Cancer; 1999 Nov; 81(5):832-4. PubMed ID: 10555753
[TBL] [Abstract][Full Text] [Related]
7. Immunomagnetic quantification of circulating tumor cells in patients with urothelial cancer.
Okegawa T; Hayashi K; Hara H; Nutahara K; Higashihara E
Int J Urol; 2010 Mar; 17(3):254-8. PubMed ID: 20148989
[TBL] [Abstract][Full Text] [Related]
8. Detection of circulating cancer cells by reverse transcription-polymerase chain reaction for uroplakin II in peripheral blood of patients with urothelial cancer.
Lu JJ; Kakehi Y; Takahashi T; Wu XX; Yuasa T; Yoshiki T; Okada Y; Terachi T; Ogawa O
Clin Cancer Res; 2000 Aug; 6(8):3166-71. PubMed ID: 10955799
[TBL] [Abstract][Full Text] [Related]
9. Detection of hematogenous micrometastasis in patients with transitional cell carcinoma.
Güdemann CJ; Weitz J; Kienle P; Lacroix J; Wiesel MJ; Soder M; Benner A; Staehler G; Doeberitz MV
J Urol; 2000 Aug; 164(2):532-6. PubMed ID: 10893639
[TBL] [Abstract][Full Text] [Related]
10. Relationship of blood groups and transitional cell carcinoma of the bladder.
Kirkali Z; Eryigit M
Int Urol Nephrol; 1993; 25(3):255-7. PubMed ID: 8225826
[TBL] [Abstract][Full Text] [Related]
11. Prurigo nodularis as initial presentation of metastatic transitional cell carcinoma of the bladder.
Lin JT; Wang WH; Yen CC; Yu IT; Chen PM
J Urol; 2002 Aug; 168(2):631-2. PubMed ID: 12131324
[No Abstract] [Full Text] [Related]
12. [Expression and clinical significance of nuclear matrix protein 22 and cytokeratin 18 in transitional cell carcinoma of the bladder].
Song JW; DU LL; Zhao XW; Jing JX; Han CZ; Cui Y; Liu JW; Hao HL; Wang ZG; Mi ZG
Zhonghua Zhong Liu Za Zhi; 2009 Apr; 31(4):274-7. PubMed ID: 19615282
[TBL] [Abstract][Full Text] [Related]
13. ABO blood groups and their relationship to transitional cell carcinoma of the urinary bladder in 30 Jordanian patients.
Murshidi MS
Acta Urol Belg; 1988; 56(4):517-22. PubMed ID: 3207084
[No Abstract] [Full Text] [Related]
14. The molecular detection of circulating tumor cells in bladder cancer using telomerase activity.
Soria JC; Morat L; Durdux C; Housset M; Cortez A; Blaise R; Sabatier L
J Urol; 2002 Jan; 167(1):352-6. PubMed ID: 11743355
[TBL] [Abstract][Full Text] [Related]
15. Molecular staging of bladder cancer with RT-PCR assay for CK20 in peripheral blood, bone marrow and lymph nodes: comparison with standard histological staging.
Ribal MJ; Mengual L; Marín M; Algaba F; Ars E; Fernández PL; Oliva R; Villavicencio H; Alcaraz A
Anticancer Res; 2006; 26(1A):411-9. PubMed ID: 16475726
[TBL] [Abstract][Full Text] [Related]
16. Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma.
Klein A; Zemer R; Buchumensky V; Klaper R; Nissenkorn I
Cancer; 1998 Jan; 82(2):349-54. PubMed ID: 9445193
[TBL] [Abstract][Full Text] [Related]
17. Circulating tumor cells in metastatic colorectal cancer: efficacy and feasibility of different enrichment methods.
Königsberg R; Gneist M; Jahn-Kuch D; Pfeiler G; Hager G; Hudec M; Dittrich C; Zeillinger R
Cancer Lett; 2010 Jul; 293(1):117-23. PubMed ID: 20167419
[TBL] [Abstract][Full Text] [Related]
18. Value of reverse transcription polymerase chain assay in peripheral blood of patients with urothelial cancer.
Okegawa T; Kinjo M; Nutahara K; Higashihara E
J Urol; 2004 Apr; 171(4):1461-6. PubMed ID: 15017198
[TBL] [Abstract][Full Text] [Related]
19. Detection of epidermal growth factor receptor mRNA in peripheral blood: a new marker of circulating neoplastic cells in bladder cancer patients.
Gazzaniga P; Gandini O; Giuliani L; Magnanti M; Gradilone A; Silvestri I; Gianni W; Gallucci M; Frati L; Aglianò AM
Clin Cancer Res; 2001 Mar; 7(3):577-83. PubMed ID: 11297251
[TBL] [Abstract][Full Text] [Related]
20. Analysis of hTERT expression in exfoliated cells from patients with bladder transitional cell carcinomas using SYBR green real-time fluorescence quantitative PCR.
Xie XY; Yang X; Zhang JH; Liu ZJ
Ann Clin Biochem; 2007 Nov; 44(Pt 6):523-8. PubMed ID: 17961306
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
